3D Bioprinting Market, By Technology (Injekt 3D, Microextrusion, Laser-Assisted, Magnetic 3D, Others), By Application (Tissue & Organ Generation, Prosthetics, Bio Sensors, Bioinks, Medical Pills), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecast 2032

The global 3D Bioprinting market is estimated at USD 2.01 billion in 2022, registering at a promising CAGR of 17.54% from 2023 to 2032. The historic year considered is 2019-2020 and the base year considered for the study is 2021, the estimated year is 2022 and the forecast has been provided for the period 2023 to 2032.

3D Bioprinting Market is projected to register high demand during the forecast period with increasing demand from major technology such as Inkjet 3D Bioprinting, Microextrusion Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting, and others during the forecast period. 3D bioprinting is used to improve numerous disease models. It has the potential to review disease models better than any other system. In October 2018, the food and drug administration (USFDA) announced a grant of approximately USD 2.5 million to top five research institutes of the US, including Harvard and Massachusetts for bio manufacturing, which includes 3D bioprinting. 

3D Bioprinting Market

Figure 1: 3D Bioprinting Market

Segment Analysis

On basis of technology, the 3D bioprinting market has been segmented into inkjet 3D bioprinting, microextrusion bioprinting, laser-assisted bioprinting, and magnetic 3D bioprinting. In April 2019, Adam Feinberg launched a new 3D bioprinting of organic bone structures, which is a combination of bio polymer and ceramic bio glass. Moreover, in 2016, the University of Plymouth developed a skin substitute similar to the human skin.

The market is competitive in nature. Key market players are Luxexcel Group B.V., Organovo Holding, Inc., 3Dynamics Systems Ltd., Cyfuse Biomedical K.K., LLC Aspect Biosystems Ltd., TeVidoBioDevices, and Stratasys Ltd., among others. Companies are engaged in new product launches, mergers and acquisitions, and regional expansions to retain their market share. For instance, in October 2017, L’oreal entered into an agreement with Organovo Holding for producing skin tissues to curb animal testing.

Key Factors Impacting Market Growth:

  • Increasing use of 3D printing technology in healthcare application
  • Increasing demand for tissue reconstruction
  • Technological developments in oral dosages..

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the 3D bioprinting market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for 3D bioprinting market during the forecast period. 

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for 3D bioprinting market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for 3D bioprinting market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for 3D bioprinting during the forecast period.

Companies Covered: Luxexcel Group B.V., Organovo Holding, Inc., 3Dynamics Systems Ltd., Cyfuse Biomedical K.K., LLC Aspect Biosystems Ltd., TeVidoBioDevices, and Stratasys Ltd…

Market Segmentation:

By Technology

  • Inkjet 3D Bioprinting
  • Microextrusion Bioprinting
  • Laser-assisted Bioprinting
  • Magnetic 3D Bioprinting
  • Others

By Application

  • Tissue & Organ Generation
  • Medical Pills
  • Prosthetic
  • Biosensors
  • Bioinks

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Technology
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Technology
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Technology
    • By Application   
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Technology
    • By Application   
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Technology
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Technology
    • By Application 

Reasons To Buy This Report:

  • Market size estimation of the 3D bioprinting market on regional and global basis
  • Unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact:sales@quincemarketinsights.com